Home > Insider Trading > Filing (0001062993-23-004080)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1372299	Ocugen Inc.	OCGN	Biological Products, (No Disgnostic Substances) (2836)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1791820	Shankar Musunuri	C/O Ocugen, Inc. 11 Great Valley Parkway Malvern PA 19355	Chief Executive Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2023-01-03	37,877	$1.25	2,190,073	No	4	F	Direct
Common Stock	Acquisiton	2023-02-16	100,000	$0.33	2,290,073	No	4	M	Direct
Common Stock	Disposition	2023-02-16	100,000	$1.08	2,190,073	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	F	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Option (Right to Buy)	Disposition	2023-02-16	100,000	$0.00	100,000	$0.33

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
529,764		2030-05-07	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	1,145,299	Indirect	By: KVM Holdings, LLC

Footnotes

This Form 4 is being filed late due to an administrative error.
This sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $1.06 to $1.10. The Reporting Person undertakes to provide Ocugen, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
The Reporting Person is a member and officer of KVM Holdings, LLC and has voting and investment power over the shares held by KVM Holdings, LLC.
The options, initially representing a right to purchase 1,357,145 shares, vest and become exercisable in equal annual installments over three years commencing on May 7, 2021, subject to continued service with the Company on the applicable vesting dates.